Evidence map›Paper›PMID 20584291›Full record

Trial reportCritical care (London, England)2010

Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury.

Markus Béchir, Milo A Puhan, Simona B Neff, Merlin Guggenheim, Volker Wedler, John F Stover, Reto Stocker, Thomas A Neff

Registry-linked trialOpen access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Critical care (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01120730 (Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01120730 phase3completednot on this map

Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury

TypeinterventionalSponsorUniversity of ZurichRan1997 to 2009Enrolled28ConditionsSurvival, Renal FailureArmsfluid resuscitation, Fluid resuscitation
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effect of the infusion ration between frozen plasma and plasma substitutes on the prognosis of adult patients with major burn in shock stage.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Burn resuscitation.Scandinavian journal of trauma, resuscitation and emergency medicine · 2011
    Review
  12. Burns: Pathophysiology of Systemic Complications and Current Management.Journal of burn care & research : official publication of the American Burn Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Markus BéchirDivision of Surgical Intensive Care, University Hospital of Zurich, Raemistrasse 100, Zurich 8091, Switzerland. markus.bechir@usz.ch
Milo A Puhan
Simona B Neff
Merlin Guggenheim
Volker Wedler
John F Stover
Reto Stocker
Thomas A Neff
University Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite large experience in the management of severe burn injury, there are still controversies regarding the best type of fluid resuscitation, especially during the first 24 hours after the trauma. Therefore, our study addressed the question whether hyperoncotic hydroxyethyl starch (HES) 200/0.5 (10%) administered in combination with crystalloids within the first 24 hours after injury is as effective as 'crystalloids only' in severe burn injury patients.

methods30 consecutive patients were enrolled to this prospective interventional open label study and assigned either to a traditional 'crystalloids only' or to a 'HES 200/0.5 (10%)' volume resuscitation protocol. Total amount of fluid administration, complications such as pulmonary failure, abdominal compartment syndrome, sepsis, renal failure and overall mortality were assessed. Cox proportional hazard regression analysis was performed for binary outcomes and adjustment for potential confounders was done in the multivariate regression models. For continuous outcome parameters multiple linear regression analysis was used.

resultsGroup differences between patients receiving crystalloids only or HES 200/0.5 (10%) were not statistically significant. However, a large effect towards increased overall mortality (adjusted hazard ratio 7.12; P = 0.16) in the HES 200/0.5 (10%) group as compared to the crystalloids only group (43.8% versus 14.3%) was present. Similarly, the incidence of renal failure was 25.0% in the HES 200/0.5 (10%) group versus 7.1% in the crystalloid only group (adjusted hazard ratio 6.16; P = 0.42).

conclusionsThis small study indicates that the application of hyperoncotic HES 200/0.5 (10%) within the first 24 hours after severe burn injury may be associated with fatal outcome and should therefore be used with caution.

trial registrationNCT01120730.

Indexed as

AdultAgedBurnsCrystalloid SolutionsFemaleFluid TherapyHumansHydroxyethyl Starch DerivativesIsotonic SolutionsMaleMiddle AgedPlasma SubstitutesProspective StudiesRegression AnalysisTrauma Severity IndicesTreatment OutcomeCrystalloid SolutionsHydroxyethyl Starch DerivativesIsotonic SolutionsPlasma Substitutes

Identifiers

PMID20584291
PMCPMC2911771
OpenAlexW2152916122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.